Zhejiang Chengyi Pharmaceutical Co., Ltd founded in 1966, is a comprehensive modern pharmaceutical company, specialized in professional production of capsules, injections, tablets, APIs and pharmaceutical intermediates. It is one of the national key high-tech enterprises, the national high credibility units, provincial and municipal key enterprises, and the leading enterprises in Dongtou District. On March 15, 2017, it was listed on the main board of the Shanghai Stock Exchange.
The company can produce more than 60 kinds, nearly hundred standards of drugs. Our main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on. All products have got the National GMP certification, a number of products get the certification from the United States FDA, EU EMEA, Australia TGA, the United Kingdom MHRA, Mexico Cofepris and some other countries.
Good faith to the world, trying to benefits people's life. Chengyi pharmaceutical company has been acting in the spirit of " diligence, rigor innovation and dedication" for more than 50 years. It sincerely serves the people, and effectively guarantees their well-being. Through high-quality products, excellent service, and good reputation, it has established a good relationship of cooperation with domestic and foreign customers, and won the trust of the vast number of users.
Take grand view, select carefully and act with restraint on the base of a large accumulation. In the future, the Chengyi pharmaceutical industry will take the marine medicine, the biological pharmacy, the Chinese Medicine and the new preparation as the main development directions, at the same time develops the healthy industry, implements the marketing change, fully builds the company's core competitive power. With the advantage of being on the board of the Shanghai Stock Exchange, through mergers and acquisitions, share holding and other forms, it will gradually, actively and steadily come into the capital market, so that the industrial chain can be extended to achieve the company's leap-forward development, and to create a new legend of marine medicine!